EU Commission writes to CMC in response to industry concerns over device labelling decision
This article was originally published in Clinica
Executive Summary
The European Commission's Directorate General for Health and Consumer Policy (DG Sanco) has written to the Central Management Committee regarding the latter's Decision No 3 on device labelling. This decision, issued last July (www.clinica.co.uk, 18 July 2011), requires the full postal address of manufacturers and authorised representatives to be placed on medical devices.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.